Our President and Managing Director, Ms. Jennifer Che, and Principal, Ms. Pauli Wong, have been invited by the HKUST, Office of Knowledge Transfer to be speakers at the IP seminar – ‘Bright Ideas, Strong Barriers: A Patenting Masterclass’ on June 26, 2024 (Wednesday) from 15:00-16:15 at the HKUST- Chow Tak Sin Lecture Theater G (LT-G).

The seminar will be divided into two parts and focus on the following topics:

1) IP Basics, Innovation Oversight and Tips: Patent 101 and Top IP Mistakes By Start-Ups & Entrepreneurs by Ms. Pauli Wong

2) MedTech & Healthcare Hurdles: IP Challenges for Innovations in the GBA and China by Ms. Jennifer Che

This seminar is designed to enhance the understanding and awareness on IP and its significance in the academic and research fields.



Our Past Events

Recommended Insights

Chinese Courts Cares More About Patent Quality Now (A Doctrine of Equivalents Story)

13 December 2022
There is no doubt that the drafting quality of a patent can be crucial in determining the success (or failure!) of the patent during litigation. However, due to various reasons, patents often fail to use the right drafting strategies that best protect the invention. Too often, inexperienced or unsophisticated patent drafters merely listen to an […]

Markush claims in China - what can be arbitrarily deleted during invalidation?

4 December 2018
Since 2010, the China Patent Re-examination Board (PRB) has published the top 10 patent invalidation cases of the year in April of each year. The selection criteria are high social concern, significant impact on the related industry, or involve difficult legal issues and important examination criteria. Below is one of the top 10 cases that […]

China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)

30 April 2021
This is Part III of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]

Inventive Step for an Enantiomer over a Racemate: “L-ornidazole” Patent Invalidation Case

27 November 2023
Each year, China’s Supreme People’s Court (SPC) issues its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in the previous year. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]
Top crossarrow-right